Kevan Clemens, a director of MEI Pharma, just received 50,000 options from the company. The strike price of the options received was $2.95, and these expire on July 01, 2031. Clemens now owns at least 50,000 options on the company.
Some additional info was provided as follows:
The options will vest in equal monthly installments over twelve months.
All of such options are presently exercisable.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever MEI Pharma makes a similar move, sign up!
